Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
Introduced
Jan 8, 2025
Last Action
Feb 3, 2026
Session
NY 2025-2026
Sponsors
1 primary · 2 co
REFERRED TO HEALTH
DELIVERED TO ASSEMBLY
PASSED SENATE
ADVANCED TO THIRD READING
2ND REPORT CAL.
1ST REPORT CAL.164
RETURNED TO SENATE
DIED IN ASSEMBLY
REFERRED TO HEALTH
REFERRED TO HEALTH
DELIVERED TO ASSEMBLY
PASSED SENATE
ADVANCED TO THIRD READING
2ND REPORT CAL.
1ST REPORT CAL.269
REFERRED TO HEALTH
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
REFERRED TO HEALTH
Nathalia Fernandez